| __timestamp | Apellis Pharmaceuticals, Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 79435000 |
| Thursday, January 1, 2015 | 13730311 | 162644000 |
| Friday, January 1, 2016 | 22978599 | 237939000 |
| Sunday, January 1, 2017 | 40303878 | 168435000 |
| Monday, January 1, 2018 | 105285576 | 173797000 |
| Tuesday, January 1, 2019 | 220968770 | 113842000 |
| Wednesday, January 1, 2020 | 299921000 | 747027000 |
| Friday, January 1, 2021 | 420869000 | 2534508000 |
| Saturday, January 1, 2022 | 387236000 | 1235278000 |
| Sunday, January 1, 2023 | 354387000 | 737502000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, innovation is key to staying ahead. Apellis Pharmaceuticals, Inc. and Novavax, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Novavax has consistently outpaced Apellis in R&D spending, peaking in 2021 with an investment that was nearly 500% higher than its 2014 expenditure. This surge coincides with the global demand for vaccines, highlighting Novavax's strategic focus on innovation during critical times.
Apellis, while spending less overall, has shown a steady increase in R&D investment, with a notable 400% rise from 2014 to 2021. This reflects a commitment to long-term growth and innovation. As the pharmaceutical landscape continues to shift, these companies' R&D strategies will be crucial in determining their future success.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Novavax, Inc.
R&D Insights: How Pfizer Inc. and Novavax, Inc. Allocate Funds
R&D Spending Showdown: Zoetis Inc. vs Novavax, Inc.
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Pharming Group N.V. and Novavax, Inc.
Comparing Innovation Spending: TG Therapeutics, Inc. and Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.